» Articles » PMID: 14750904

Phosphorylation of Clock Protein PER1 Regulates Its Circadian Degradation in Normal Human Fibroblasts

Overview
Journal Biochem J
Specialty Biochemistry
Date 2004 Jan 31
PMID 14750904
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Recent advances suggest that the molecular components of the circadian clock generate a self-sustaining transcriptional-translational feedback loop with a period of approx. 24 h. The precise expression profiles of human clock genes and their products have not been elucidated. We cloned human clock genes, including per1, per2, per3, cry2 and clock, and evaluated their circadian mRNA expression profiles in WI-38 fibroblasts stimulated with serum. Transcripts of hPer1, hPer2, hPer3, hBMAL1 and hCry2 (where h is human) underwent circadian oscillation. Serum-stimulation also caused daily oscillations of hPER1 protein and the apparent molecular mass of hPER1 changed. Inhibitor studies indicated that the CKI (casein kinase I) family, including CKIepsilon and CKIdelta, phosphorylated hPER1 and increased the apparent molecular mass of hPER1. The inhibition of hPER1 phosphorylation by CKI-7 [ N -(2-aminoethyl)-5-chloro-isoquinoline-8-sulphonamide], a CKI inhibitor, disturbed hPER1 degradation, delayed the nuclear entry of hPER1 and allowed it to persist for longer in the nucleus. Furthermore, proteasome inhibitors specifically blocked hPER1 degradation. However leptomycin B, an inhibitor of nuclear export, did not alter the degradation state of hPER1 protein. These findings indicate that circadian hPER1 degradation through a proteasomal pathway can be regulated through phosphorylation by CKI, but not by subcellular localization.

Citing Articles

Hierarchical and scaffolded phosphorylation of two degrons controls PER2 stability.

Francisco J, Virshup D J Biol Chem. 2024; 300(6):107391.

PMID: 38777144 PMC: 11223080. DOI: 10.1016/j.jbc.2024.107391.


Disruption in the regulation of casein kinase 2 in circadian rhythm leads to pathological states: cancer, diabetes and neurodegenerative disorders.

Malik M, Dashti M, Fatima Y, Channanath A, John S, Brojen Singh R Front Mol Neurosci. 2023; 16:1217992.

PMID: 37475884 PMC: 10354274. DOI: 10.3389/fnmol.2023.1217992.


The time dimension to stroke: Circadian effects on stroke outcomes and mechanisms.

Kamat P, Badruzzaman Khan M, Smith C, Siddiqui S, Baban B, Dhandapani K Neurochem Int. 2022; 162:105457.

PMID: 36442686 PMC: 9839555. DOI: 10.1016/j.neuint.2022.105457.


Mood phenotypes in rodent models with circadian disturbances.

Imamura K, Takumi T Neurobiol Sleep Circadian Rhythms. 2022; 13:100083.

PMID: 36345502 PMC: 9636574. DOI: 10.1016/j.nbscr.2022.100083.


Circadian clock-based therapeutics in chronic pulmonary diseases.

Giri A, Rahman I, Sundar I Trends Pharmacol Sci. 2022; 43(12):1014-1029.

PMID: 36302705 PMC: 9756397. DOI: 10.1016/j.tips.2022.09.004.


References
1.
Akten B, Jauch E, Genova G, Kim E, Edery I, Raabe T . A role for CK2 in the Drosophila circadian oscillator. Nat Neurosci. 2003; 6(3):251-7. DOI: 10.1038/nn1007. View

2.
Naidoo N, Song W, Sehgal A . A role for the proteasome in the light response of the timeless clock protein. Science. 1999; 285(5434):1737-41. DOI: 10.1126/science.285.5434.1737. View

3.
Edery I, Zwiebel L, Dembinska M, Rosbash M . Temporal phosphorylation of the Drosophila period protein. Proc Natl Acad Sci U S A. 1994; 91(6):2260-4. PMC: 43350. DOI: 10.1073/pnas.91.6.2260. View

4.
Fish K, Cegielska A, Getman M, Landes G, Virshup D . Isolation and characterization of human casein kinase I epsilon (CKI), a novel member of the CKI gene family. J Biol Chem. 1995; 270(25):14875-83. DOI: 10.1074/jbc.270.25.14875. View

5.
Ohara O, Nagase T, Ishikawa K, Nakajima D, Ohira M, Seki N . Construction and characterization of human brain cDNA libraries suitable for analysis of cDNA clones encoding relatively large proteins. DNA Res. 1997; 4(1):53-9. DOI: 10.1093/dnares/4.1.53. View